Search all trials

Find therapies in clinical trials near you – page 7

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Study on the Immune Response and Safety of RSVPreF3 OA Vaccine Alone and with COVID-19 mRNA Vaccine in Adults Aged 50 and Above

Not recruiting

Registered drugNo placebo

Study on the Immune Response and Safety of RSVPreF3 OA Vaccine Alone and with COVID-19 mRNA Vaccine in Adults Aged 50 and Above

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years · Healthy volunteers
Substances:Raxtozinameran

Contact Research Centre

Peripheral arterial occlusive disease

Not recruiting

Registered drugNo placebo

Study on Genotype-Guided Treatment with Carbasalate Calcium, Telmisartan, and Rivaroxaban for Patients with Peripheral Arterial Disease

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Carbasalate Calcium

Contact Research Centre

Nephrotic syndrome

Not recruiting

Investigational

Study of levamisole and prednisolone combination to prevent nephrotic syndrome relapse in children aged 2-16 years with first episode of steroid-sensitive disease

Investigational

The Netherlands

Participants:0–17 years
Substances:Levamisole Hydrochloride

Contact Research Centre

Breast cancer metastatic

Not recruiting

Registered drugNo placebo

Study comparing carboplatin-cyclophosphamide versus paclitaxel with atezolizumab as first treatment for advanced triple negative breast cancer

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Atezolizumab

Contact Research Centre

Peripheral artery restenosis+4

Not recruiting

Registered drug

Study on the Effect of Clopidogrel and Acetylsalicylic Acid on Reducing Heart and Blood Vessel Events in Patients with Peripheral Arterial Disease

Registered drug

The Netherlands

Participants:18–64 years · 65+ years
Substances:Acetylsalicylic Acid

Contact Research Centre

Acute myeloid leukaemia+1

Not recruiting

Registered drugNo placebo

Study Comparing Gilteritinib and Midostaurin with Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with FLT3 Mutation

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Gilteritinib

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study of reduced pembrolizumab dosing compared to standard dose in patients with advanced non-small cell lung cancer

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Hormone receptor positive HER2 negative breast cancer+1

Not recruiting

Registered drugNo placebo

Study on Alpelisib and Fulvestrant for Advanced Breast Cancer in Patients with PIK3CA Mutation and Hormone-Receptor Positive, HER2 Negative Tumors

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Alpelisib

Contact Research Centre

Malignant melanoma

Not recruiting

Registered drugNo placebo

Study on Early Discontinuation of Nivolumab and Ipilimumab in Patients with Advanced Melanoma

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Ipilimumab

Contact Research Centre

Multiple sclerosis

Not recruiting

Registered drugNo placebo

Study on Personalized Ocrelizumab Dosing for Patients with Relapsing Remitting Multiple Sclerosis

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Ocrelizumab

Contact Research Centre

Rheumatoid arthritis

Not recruiting

Registered drugNo placebo

Study on Rheumatoid Arthritis: Evaluating Methotrexate, Golimumab, and Hydroxychloroquine Sulfate for Patients with Autoantibodies and Response to Glucocorticoids

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Adalimumab

Contact Research Centre

Acute myeloid leukaemia+1

Not recruiting

Investigational

Study of Ivosidenib or Enasidenib with Chemotherapy for Patients with Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with IDH1 or IDH2 Mutation

Investigational

The Netherlands

Participants:18–64 years · 65+ years
Substances:Enasidenib Mesilate

Contact Research Centre

Find therapies in clinical trials near you – page 7

110 trials match your criteria

Study on the Immune Response and Safety of RSVPreF3 OA Vaccine Alone and with COVID-19 mRNA Vaccine in Adults Aged 50 and Above

Study on the Immune Response and Safety of RSVPreF3 OA Vaccine Alone and with COVID-19 mRNA Vaccine in Adults Aged 50 and Above

Peripheral arterial occlusive disease

Study on Genotype-Guided Treatment with Carbasalate Calcium, Telmisartan, and Rivaroxaban for Patients with Peripheral Arterial Disease

Nephrotic syndrome

Study of levamisole and prednisolone combination to prevent nephrotic syndrome relapse in children aged 2-16 years with first episode of steroid-sensitive disease

Breast cancer metastatic

Study comparing carboplatin-cyclophosphamide versus paclitaxel with atezolizumab as first treatment for advanced triple negative breast cancer

Peripheral artery restenosis+4

Study on the Effect of Clopidogrel and Acetylsalicylic Acid on Reducing Heart and Blood Vessel Events in Patients with Peripheral Arterial Disease

Acute myeloid leukaemia+1

Study Comparing Gilteritinib and Midostaurin with Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with FLT3 Mutation

Non-small cell lung cancer

Study of reduced pembrolizumab dosing compared to standard dose in patients with advanced non-small cell lung cancer

Hormone receptor positive HER2 negative breast cancer+1

Study on Alpelisib and Fulvestrant for Advanced Breast Cancer in Patients with PIK3CA Mutation and Hormone-Receptor Positive, HER2 Negative Tumors

Malignant melanoma

Study on Early Discontinuation of Nivolumab and Ipilimumab in Patients with Advanced Melanoma

Multiple sclerosis

Study on Personalized Ocrelizumab Dosing for Patients with Relapsing Remitting Multiple Sclerosis

Rheumatoid arthritis

Study on Rheumatoid Arthritis: Evaluating Methotrexate, Golimumab, and Hydroxychloroquine Sulfate for Patients with Autoantibodies and Response to Glucocorticoids

Acute myeloid leukaemia+1

Study of Ivosidenib or Enasidenib with Chemotherapy for Patients with Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with IDH1 or IDH2 Mutation

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.